Identification of binding partners interacting with the α1-N-propeptide of type V collagen

Biochemical Journal

Volumn 433, Issue 2, 2011, Pages 371-381

  Symoens, Sofie ^a   Renard, Marjolijn ^a   Bonod Bidaud, Christelle ^b   Syx, Delfien ^a   Vaganay, Elisabeth ^b   Malfait, Fransiska ^a   Ricard Blum, Sylvie ^b   Kessler, Efrat ^c   Van Laer, Lut ^a   Coucke, Paul ^a   Ruggiero, Florence ^b   De Paepe, Anne ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITÉ LYON 1   (France)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

1 N propeptide; Ehlers Danlos syndrome; Extracellular matrix; Fibrillogenesis; Type V collagen

Indexed keywords

ALPHA 1 N PROPEPTIDE; COLLAGEN FIBRIL; COLLAGEN TYPE 5; COLLAGEN TYPE 6; FIBRONECTIN; GELATINASE A; PROCOLLAGEN C PROTEINASE; SCLEROPROTEIN; TENASCIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ARTICLE; BINDING ASSAY; COLLAGEN SYNTHESIS; CONTROLLED STUDY; EHLERS DANLOS SYNDROME; EXTRACELLULAR MATRIX; FIBROBLAST; GENE MUTATION; HOMEOSTASIS; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; JOINT HYPERMOBILITY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SKIN; SURFACE PLASMON RESONANCE; YEAST;

COLLAGEN TYPE V; EHLERS-DANLOS SYNDROME; HEK293 CELLS; HOMEOSTASIS; HUMANS; PEPTIDES; PROCOLLAGEN; PROTEIN BINDING;

EID: 78651315352     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20101061     Document Type: Article

References (51)

1. Birk, D. E. (2001) Type V collagen: heterotypic type I/V collagen interactions in the regulation of fibril assembly. Micron 32, 223-237
2. Chanut-Delalande, H., Bonod-Bidaud, C., Cogne, S., Malbouyres, M., Ramirez, F., Fichard, A. and Ruggiero, F. (2004) Development of a functional skin matrix requires deposition of collagen V heterotrimers. Mol. Cell. Biol. 24, 6049-6057
3. Wenstrup, R. J., Florer, J. B., Davidson, J. M., Phillips, C. L., Pfeiffer, B. J., Menezes, D. W., Chervoneva, I. and Birk, D. E. (2006) Murine model of the Ehlers-Danlos syndrome: col5a1haploinsufficiency disrupts collagen fibril assembly at multiple stages. J. Biol. Chem 281, 12888-12895
4. Unsold, C., Pappano, W. N., Imamura, Y., Steiglitz, B. M. and Greenspan, D. S. (2002) Biosynthetic processing of the pro-α1(V)2pro-α2(V) collagen heterotrimer by bone morphogenetic protein-1 and furin-like proprotein convertases. J. Biol. Chem. 277, 5596-5602
5. Bonod-Bidaud, C., Beraud, M., Vaganay, E., Delacoux, F., Font, B., Hulmes, D. J. and Ruggiero, F. (2007) Enzymatic cleavage specificity of the proα1(V) chain processing analysed by site-directed mutagenesis. Biochem. J. 405, 299-306
6. Colige, A., Ruggiero, F., Vandenberghe, I., Dubail, J., Kesteloot, F., Van Beeumen, J., Beschin, A., Brys, L., Lapiere, C. M. and Nusgens, B. (2005) Domains and maturation processes that regulate the activity of ADAMTS-2, a metalloproteinase cleaving the aminopropeptide of fibrillar procollagens types I-III and V. J. Biol. Chem. 280, 34397-34408
7. Hausser, I. and Anton-Lamprecht, I. (1994) Differential ultrastructural aberrations of collagen fibrils in Ehlers-Danlos syndrome types I-IV as a means of diagnostics and classification. Hum. Genet. 93, 394-407
8. Malfait, F., Coucke, P., Symoens, S., Loeys, B., Nuytinck, L. and De Paepe, A. (2005) The molecular basis of classic Ehlers-Danlos syndrome: a comprehensive study of biochemical and molecular findings in 48 unrelated patients. Hum. Mutat. 25, 28-37
9. Mitchell, A. L., Schwarze, U., Jennings, J. F. and Byers, P. H. (2009) Molecular mechanisms of classical Ehlers-Danlos syndrome (EDS). Hum. Mutat. 30, 995-1002
10. Symoens, S., Malfait, F., Renard, M., Andre, J., Hausser, I., Loeys, B., Coucke, P. and De Paepe, A. (2009) COL5A1 signal peptide mutations interfere with protein secretion and cause classic Ehlers-Danlos syndrome. Hum. Mutat. 30, E395-E403
11. Giunta, C., Nuytinck, L., Raghunath, M., Hausser, I., De Paepe, A. and Steinmann, B. (2002) Homozygous Gly530Ser substitution in COL5A1 causes mild classical Ehlers-Danlos syndrome. Am. J. Med. Genet. 109, 284-290
12. Takahara, K., Schwarze, U., Imamura, Y., Hoffman, G. G., Toriello, H., Smith, L. T., Byers, P. H. and Greenspan, D. S. (2002) Order of intron removal influences multiple splice outcomes, including a two-exon skip, in a COL5A1 acceptor-site mutation that results in abnormal pro-α1(V) N-propeptides and Ehlers-Danlos syndrome type I. Am. J. Hum. Genet. 71, 451-465
13. Fichard, A., Kleman, J. P. and Ruggiero, F. (1995) Another look at collagen V and XI molecules. Matrix Biol. 14, 515-531
14. Delacoux, F., Fichard, A., Cogne, S., Garrone, R. and Ruggiero, F. (2000) Unraveling the amino acid sequence crucial for heparin binding to collagen V. J. Biol. Chem. 275, 29377-29382
15. Whinna, H. C., Choi, H. U., Rosenberg, L. C. and Church, F. C. (1993) Interaction of heparin cofactor II with biglycan and decorin. J. Biol. Chem. 268, 3920-3924
16. Xie, R. L. and Long, G. L. (1996) Elements within the first 17 amino acids of human osteonectin are responsible for binding to type V collagen. J. Biol. Chem. 271, 8121-8125
17. Lethias, C., Carisey, A., Comte, J., Cluzel, C. and Exposito, J. Y. (2006) A model of tenascin-X integration within the collagenous network. FEBS Lett. 580, 6281-6285
18. Ruggiero, F., Champliaud, M. F., Garrone, R. and Aumailley, M. (1994) Interactions between cells and collagen V molecules or single chains involve distinct mechanisms. Exp. Cell Res. 210, 215-223
19. Vogel, W., Gish, G. D., Alves, F. and Pawson, T. (1997) The discoidin domain receptor tyrosine kinases are activated by collagen. Mol. Cell 1, 13-23
20. Behrendt, N., Jensen, O. N., Engelholm, L. H., Mortz, E., Mann, M. and Dano, K. (2000) A urokinase receptor-associated protein with specific collagen binding properties. J. Biol. Chem. 275, 1993-2002
21. Van Criekinge, W. and Beyaert, R. (1999) Yeast two-hybrid: state of the art. Biol. Proced. Online 2, 1-38
22. Ricard-Blum, S., Bernocco, S., Font, B., Moali, C., Eichenberger, D., Farjanel, J., Burchardt, E. R., Van Der Rest, M., Kessler, E. and Hulmes, D. J. (2002) Interaction properties of the procollagen C-proteinase enhancer protein shed light on the mechanism of stimulation of BMP-1. J. Biol. Chem. 277, 33864-33869
23. Faye, C., Chautard, E., Olsen, B. R. and Ricard-Blum, S. (2009) The first draft of the endostatin interaction network. J. Biol. Chem. 284, 22041-22047
24. Kessler, E. and Adar, R. (1989) Type I procollagen C-proteinase from mouse fibroblasts: purification and demonstration of a 55-kDa enhancer glycoprotein. Eur. J. Biochem. 186, 115-121
25. Kessler, E., Fichard, A., Chanut-Delalande, H., Brusel, M. and Ruggiero, F. (2001) Bone morphogenetic protein-1 (BMP-1) mediates C-terminal processing of procollagen V homotrimer. J. Biol. Chem. 276, 27051-27057
26. Penner, A. S., Rock, M. J., Kielty, C. M. and Shipley, J. M. (2002) Microfibril-associated glycoprotein-2 interacts with fibrillin-1 and fibrillin-2 suggesting a role for MAGP-2 in elastic fiber assembly. J. Biol. Chem. 277, 35044-35049
27. Nielsen, V. H., Bendixen, C., Arnbjerg, J., Sorensen, C. M., Jensen, H. E., Shukri, N. M. and Thomsen, B. (2000) Abnormal growth plate function in pigs carrying a dominant mutation in type X collagen. Mamm. Genome 11, 1087-1092
28. Bennett, E. P., Hassan, H., Hollingsworth, M. A. and Clausen, H. (1999) A novel human UDP- N-acetyl-D-galactosamine:polypeptide N- acetylgalactosaminyltransferase, GalNAc-T7, with specificity for partial GalNAc-glycosylated acceptor substrates. FEBS Lett. 460, 226-230
29. Chanut-Delalande, H., Fichard, A., Bernocco, S., Garrone, R., Hulmes, D. J. and Ruggiero, F. (2001) Control of heterotypic fibril formation by collagen V is determined by chain stoichiometry. J. Biol. Chem. 276, 24352-24359
30. Zoppi, N., Gardella, R., De Paepe, A., Barlati, S. and Colombi, M. (2004) Human fibroblasts with mutations in COL5A1and COL3A1genes do not organize collagens and fibronectin in the extracellular matrix, down-regulate α2β1 integrin, and recruit αvβ3 Instead of α5β1 integrin. J. Biol. Chem. 279, 18157-18168
31. Colombatti, A., Mucignat, M. T. and Bonaldo, P. (1995) Secretion and matrix assembly of recombinant type VI collagen. J. Biol. Chem. 270, 13105-13111
32. Tillet, E., Ruggiero, F., Nishiyama, A. and Stallcup, W. B. (1997) The membrane-spanning proteoglycan NG2 binds to collagens V and VI through the central nonglobular domain of its core protein. J. Biol. Chem. 272, 10769-10776
33. Higashi, K., Higuchi, I., Niiyama, T., Uchida, Y., Shiraishi, T., Hashiguchi, A., Saito, A., Horikiri, T., Suehara, M., Arimura, K. and Osame, M. (2006) Abnormal expression of proteoglycans in Ullrich's disease with collagen VI deficiency. Muscle Nerve 33, 120-126
34. Kobayasi, T. and Karlsmark, T. (2006) Type V and VI collagen for cohesion of dermal fibrillar structures. J. Submicrosc. Cytol. Pathol. 38, 103-108
35. Kirschner, J., Hausser, I., Zou, Y., Schreiber, G., Christen, H. J., Brown, S. C., Anton-Lamprecht, I., Muntoni, F., Hanefeld, F. and Bonnemann, C. G. (2005) Ullrich congenital muscular dystrophy: connective tissue abnormalities in the skin support overlap with Ehlers-Danlos syndromes. Am. J. Med. Genet. A 132, 296-301
36. Kessler, E., Takahara, K., Biniaminov, L., Brusel, M. and Greenspan, D. S. (1996) Bone morphogenetic protein-1: the type I procollagen C-proteinase. Science 271, 360-362
37. Moali, C., Font, B., Ruggiero, F., Eichenberger, D., Rousselle, P., Francois, V., Oldberg, A., Bruckner-Tuderman, L. and Hulmes, D. J. (2005) Substrate-specific modulation of a multisubstrate proteinase: C-terminal processing of fibrillar procollagens is the only BMP-1-dependent activity to be enhanced by PCPE-1. J. Biol. Chem. 280, 24188-24194
38. Gleizes, P. E., Munger, J. S., Nunes, I., Harpel, J. G., Mazzieri, R., Noguera, I. and Rifkin, D. B. (1997) TGF-β latency: biological significance and mechanisms of activation. Stem Cells 15, 190-197
39. Kahai, S., Vary, C. P., Gao, Y. and Seth, A. (2004) Collagen, type V, α1 (COL5A1) is regulated by TGF-β in osteoblasts. Matrix Biol. 23, 445-455
40. Stawowy, P., Margeta, C., Kallisch, H., Seidah, N. G., Chretien, M., Fleck, E. and Graf, K. (2004) Regulation of matrix metalloproteinase MT1-MMP/MMP-2 in cardiac fibroblasts by TGF-β1 involves furin-convertase. Cardiovasc. Res. 63, 87-97
41. Zhu, Y., Oganesian, A., Keene, D. R. and Sandell, L. J. (1999) Type IIA procollagen containing the cysteine-rich amino propeptide is deposited in the extracellular matrix of prechondrogenic tissue and binds to TGF-β1 and BMP-2. J. Cell Biol. 144, 1069-1080
42. Gunther, U., Schuppan, D., Bauer, M., Matthes, H., Stallmach, A., Schmitt-Graff, A., Riecken, E. O. and Herbst, H. (1999) Fibrogenesis and fibrolysis in collagenous colitis: patterns of procollagen types I and IV, matrix-metalloproteinase-1 and -13, and TIMP-1 gene expression. Am. J. Pathol. 155, 493-503
43. Myint, E., Brown, D. J., Ljubimov, A. V., Kyaw, M. and Kenney, M. C. (1996) Cleavage of human corneal type VI collagen α3 chain by matrix metalloproteinase-2. Cornea 15, 490-496
44. Kerkvliet, E. H., Jansen, I. C., Schoenmaker, T., Beertsen, W. and Everts, V. (2003) Collagen type I, III and V differently modulate synthesis and activation of matrix metalloproteinases by cultured rabbit periosteal fibroblasts. Matrix Biol. 22, 217-227
45. Rual, J. F., Venkatesan, K., Hao, T., Hirozane-Kishikawa, T., Dricot, A., Li, N., Berriz, G. F., Gibbons, F. D., Dreze, M., Ayivi-Guedehoussou, N. et al. (2005) Towards a proteome-scale map of the human protein-protein interaction network. Nature 437, 1173-1178
46. Gomez, D. E., Alonso, D. F., Yoshiji, H. and Thorgeirsson, U. P. (1997) Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur. J. Cell Biol. 74, 111-122
47. Freise, C., Erben, U., Muche, M., Farndale, R., Zeitz, M., Somasundaram, R. and Ruehl, M. (2009) The α2 chain of collagen type VI sequesters latent proforms of matrix-metalloproteinases and modulates their activation and activity. Matrix Biol. 28, 480-489
48. Byers, P. H., Duvic, M., Atkinson, M., Robinow, M., Smith, L. T., Krane, S. M., Greally, M. T., Ludman, M., Matalon, R., Pauker, S. et al. (1997) Ehlers-Danlos syndrome type VIIA and VIIB result from splice-junction mutations or genomic deletions that involve exon 6 in the COL1A1and COL1A2 genes of type I collagen. Am. J. Med. Genet. 72, 94-105
49. Malfait, F., Symoens, S., De Backer, J., Hermanns-Le, T., Sakalihasan, N., Lapiere, C. M., Coucke, P. and De Paepe, A. (2007) Three arginine to cysteine substitutions in the pro-α(I)-collagen chain cause Ehlers-Danlos syndrome with a propensity to arterial rupture in early adulthood. Hum. Mutat. 28, 387-395
50. Arneson, M. A., Hammerschmidt, D. E., Furcht, L. T. and King, R. A. (1980) A new form of Ehlers-Danlos syndrome: fibronectin corrects defective platelet function. JAMA, J. Am. Med. Assoc. 244, 144-147
51. Lampe, A. K. and Bushby, K. M. (2005) Collagen VI related muscle disorders. J. Med. Genet. 42, 673-685